Who invested in Entasis Therapeutics?
Entasis Therapeutics's investors include TPG, Novo Holdings, Sofinnova Investments and Pivotal bioVenture Partners.
United States · Funded startup
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$39Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Entasis Therapeutics's investors include TPG, Novo Holdings, Sofinnova Investments and Pivotal bioVenture Partners.
Entasis Therapeutics has raised $39M across 2 rounds since 2017.
Entasis Therapeutics's most recent round was an Undisclosed round of $7.5M in May 2021.
Entasis Therapeutics's largest round on record is $32M (Series B), in Sept 2017.
Entasis Therapeutics's first round on record, in Sept 2017, was backed by TPG, Sofinnova Investments and Pivotal bioVenture Partners.
Entasis Therapeutics's latest named round is an Undisclosed round, in May 2021.
Entasis Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.